University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72204, United States
Location status: Recruiting
NCT Number: NCT06186128
Universal Basic Income (UBI) is a promising strategy aimed at recalibrating economic systems that are grounded in structural racism. Black men have long been the target of oppressive and interconnected systems of finance and healthcare access, leading to a disproportionate burden of exposure to infectious disease with little healthcare support. Yet to our knowledge, no published UBI studies have ever been implemented exclusively with Black men living with HIV in the US. Motivated and inspired by the innovative health and social science being conducted in extremely resource-limited environments in other parts of the world, we recognize an urgent need to better understand the effect of cash transfers on HIV care among Black men in the US South. The proposed study will be based in Arkansas, which, like other Southern states, has a long history of institutional racism and extremely high rates of racial health disparities, poverty, and chronic disease. We will use a mixed methods research design to conduct an in-depth exploration of a UBI intervention to reduce the racial wage gap and promote the use of culturally relevant protective factors. The provision of a UBI is intended to increase receipt and retention of HIV care services and treatment for Black men through the influx of capital and subsequent increases in culturally-based protective factors such as personal agency and social connections. We hypothesize that providing UBI of $500 per month for 6 months will result in increased HIV care utilization among low-income Black men living with HIV. Secondarily, we hypothesize that the effect of UBI will also increase adherence to HIV medication, such that more UBI recipients will achieve and maintain viral suppression compared to individuals in the control condition.
Interested in participating?
Request Info25 year and older
Male
Interventional
Not applicable
Little Rock, Arkansas, 72204, United States
Location status: Recruiting
The proposed supplement from the parent R01 grant will expand on the parent grant by enrolling a larger sample (n=80) of Black men living with HIV as their diagnosed chronic disease. To date, no published UBI studies have ever been implemented exclusively with Black men living with HIV in the US. Motivated and inspired by the innovative health and social science being conducted in extremely resource-limited environments in other parts of the world, we recognize an urgent need to better understand the effect of cash transfers on HIV care among Black men in the US South. The proposed study will be based in Arkansas, which, like other Southern states, has a long history of institutional racism and extremely high rates of racial health disparities, poverty, and chronic disease. We will use a mixed methods research design to conduct an in-depth exploration of a UBI intervention to reduce the racial wage gap and promote the use of culturally relevant protective factors. The provision of a UBI is intended to increase receipt and retention of HIV care services and treatment for Black men through the influx of capital and subsequent increases in culturally-based protective factors such as personal agency and social connections. We hypothesize that providing UBI of $500 per month for 6 months will result in increased HIV care utilization among low-income Black men living with HIV. Secondarily, we hypothesize that the effect of UBI will also increase adherence to HIV medication, such that more UBI recipients will achieve and maintain viral suppression compared to individuals in the control condition. This study is designed to generate generalizable evidence to inform decisions by policymakers, scientists, and the general public about the inner-workings of UBI, the biases underlying who is deemed as "qualifying" or "deserving", and its downstream effects on public health, particularly related to access to HIV care, and structural racism.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Universal basic income (UBI) is a system that gives everyone a minimum amount of money regularly, regardless of their income or work status.
Time frame: 1 year
Defined as having at least one HIV viral load and/or CD4 count laboratory test within the six-month period of study enrollment during which the UBI intervention will be implemented at the same period. We also will use medical chart abstraction to confirm self-reported use of HIV care services.
Time frame: 1 year
We will us adherence over a 30-day period as self-reported adherence.
Time frame: 1 year
Defined as having two CD4 viral load tests performed at least three months apart
Time frame: 1 year
Defined as having a viral load test result of <200 copies/ml
Time frame: 1 year
Will be assess at all three data collection time points (Baseline, 6-, and 12-month)
Contact information is provided by the study sponsor or research team.
Ashley E Williams, MHS
CONTACT
Brooke Montgomery, PhD
CONTACT
University of Arkansas
Other
Universal Basic Income and Structural Racism in the US South: Differences in HIV Care Utilization Between Low-income African American Men Living With HIV
Acronym: 017744S
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06999928
Acquired Immunodeficiency Syndrome, Adherence, Treatment
Burnt Forest, Uasin Gishu County, Kenya
View Trial DetailsNCT06629753
Acquired Immunodeficiency Syndrome, Behavior
Eldoret, Uasin Gishu County, Kenya
View Trial DetailsNCT05282173
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Cape Town, Western Cape, South Africa
View Trial DetailsNCT02447159
Behavior, Blood-Borne Infections
Eket, Akwa Ibom State, Nigeria
View Trial Details